The Biotech Growth Trust PLC (BIOG) - Total Assets

Latest as of September 2025: GBX289.97 Million GBX ≈ $35.28K USD

Based on the latest financial reports, The Biotech Growth Trust PLC (BIOG) holds total assets worth GBX289.97 Million GBX (≈ $35.28K USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check cash flow reinvestment rate of The Biotech Growth Trust PLC to assess the company's total reinvestment commitment from operating cash flow.

The Biotech Growth Trust PLC - Total Assets Trend (2004–2025)

This chart illustrates how The Biotech Growth Trust PLC's total assets have evolved over time, based on quarterly financial data. Explore The Biotech Growth Trust PLC long-term investment allocation to see how much of total assets are deployed in long-term investments.

The Biotech Growth Trust PLC - Asset Composition Analysis

Current Asset Composition (March 2025)

The Biotech Growth Trust PLC's total assets of GBX289.97 Million consist of 3.7% current assets and 96.3% non-current assets.

Asset Category	Amount (GBX)	% of Total Assets
Cash & Equivalents	GBX0.00	3.7%
Accounts Receivable	GBX0.00	0.0%
Inventory	GBX0.00	0.0%
Property, Plant & Equipment	GBX0.00	0.0%
Intangible Assets	GBX0.00	0.0%
Goodwill	GBX0.00	0.0%

Asset Composition Trend (2004–2025)

This chart illustrates how The Biotech Growth Trust PLC's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see BIOG market cap.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: The Biotech Growth Trust PLC's current assets represent 3.7% of total assets in 2025, an increase from 1.0% in 2004.
Cash Position: Cash and equivalents constituted 3.7% of total assets in 2025, up from 0.9% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2004.
Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.

The Biotech Growth Trust PLC Competitors by Total Assets

Key competitors of The Biotech Growth Trust PLC based on total assets are shown below.

Company	Country	Total Assets
Metrics Master Income Trust AU:MXT	Australia	AU$2.46 Billion
Jpmorgan Global Core Real Assets Ltd LSE:JARA	UK	GBX70.85 Million
Northern Trust Corporation NASDAQ:NTRS	USA	$174.57 Billion
Principal Financial Group Inc NASDAQ:PFG	USA	$332.70 Billion
Industrivarden AB ser. C ST:INDU-C	Sweden	Skr211.38 Billion
Sprott Physical Gold and Silver Trust TO:CEF	Canada	CA$9.34 Billion
Anxin Trust Co Ltd SHG:600816	China	CN¥26.40 Billion
Norte Grande SN:NORTEGRAN	Chile	CL$2.96 Billion

The Biotech Growth Trust PLC - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	20.91	0.32	0.07
Quick Ratio	20.91	0.32	0.07
Cash Ratio	0.00	0.00	0.00
Working Capital	GBX8.06 Million	GBX-35.85 Million	GBX-33.12 Million

The Biotech Growth Trust PLC - Advanced Valuation Insights

This section examines the relationship between The Biotech Growth Trust PLC's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	0.96
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	-44.9%
Total Assets	GBX226.63 Million
Market Capitalization	$3.44 Million USD

Valuation Analysis

Below Book Valuation: The market values The Biotech Growth Trust PLC's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: The Biotech Growth Trust PLC's assets decreased by 44.9% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for The Biotech Growth Trust PLC (2004–2025)

The table below shows the annual total assets of The Biotech Growth Trust PLC from 2004 to 2025.

Year	Total Assets	Change
2025-03-31	GBX226.63 Million ≈ $27.57K	-44.92%
2024-03-31	GBX411.42 Million ≈ $50.06K	+14.12%
2023-03-31	GBX360.51 Million ≈ $43.86K	-15.66%
2022-03-31	GBX427.45 Million ≈ $52.01K	-34.19%
2021-03-31	GBX649.53 Million ≈ $79.03K	+61.90%
2020-03-31	GBX401.19 Million ≈ $48.81K	-6.97%
2019-03-31	GBX431.23 Million ≈ $52.47K	-3.33%
2018-03-31	GBX446.07 Million ≈ $54.27K	-3.34%
2017-03-31	GBX461.50 Million ≈ $56.15K	+8.55%
2016-03-31	GBX425.14 Million ≈ $51.73K	-27.52%
2015-03-31	GBX586.53 Million ≈ $71.36K	+54.17%
2014-03-31	GBX380.43 Million ≈ $46.29K	+42.66%
2013-03-31	GBX266.66 Million ≈ $32.45K	+64.74%
2012-03-31	GBX161.87 Million ≈ $19.69K	+19.73%
2011-03-31	GBX135.20 Million ≈ $16.45K	+1.71%
2010-03-31	GBX132.92 Million ≈ $16.17K	+78.46%
2009-03-31	GBX74.48 Million ≈ $9.06K	+12.06%
2008-03-31	GBX66.47 Million ≈ $8.09K	-17.46%
2007-03-31	GBX80.53 Million ≈ $9.80K	+106.14%
2006-03-31	GBX39.07 Million ≈ $4.75K	+27.08%
2005-03-31	GBX30.74 Million ≈ $3.74K	-9.79%
2004-03-31	GBX34.08 Million ≈ $4.15K	--

About The Biotech Growth Trust PLC

LSE:BIOG UK Asset Management

Market Cap

$3.44 Million

GBX28.30 Billion GBX

Market Cap Rank

#29233 Global

#550 in UK

Share Price

GBX1364.00

Change (1 day)

+10.71%

52-Week Range

GBX714.00 - GBX1364.00

All Time High

GBX1736.00